Trial Profile
Phase I multiple-dose, pharmacokinetic trial of controlled-release morphine/oxycodone
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2012
Price :
$35
*
At a glance
- Drugs Morphine/oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors QRxPharma
- 20 Apr 2012 New trial record